306 related articles for article (PubMed ID: 32033023)
1. Microtubule-Associated Proteins with Regulatory Functions by Day and Pathological Potency at Night.
Oláh J; Lehotzky A; Szunyogh S; Szénási T; Orosz F; Ovádi J
Cells; 2020 Feb; 9(2):. PubMed ID: 32033023
[TBL] [Abstract][Full Text] [Related]
2. Moonlighting microtubule-associated proteins: regulatory functions by day and pathological functions at night.
Oláh J; Tőkési N; Lehotzky A; Orosz F; Ovádi J
Cytoskeleton (Hoboken); 2013 Nov; 70(11):677-85. PubMed ID: 24039085
[TBL] [Abstract][Full Text] [Related]
3. Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency.
Szabó A; Oláh J; Szunyogh S; Lehotzky A; Szénási T; Csaplár M; Schiedel M; Lőw P; Jung M; Ovádi J
Sci Rep; 2017 Dec; 7(1):17070. PubMed ID: 29213065
[TBL] [Abstract][Full Text] [Related]
4. Dual life of TPPP/p25 evolved in physiological and pathological conditions.
Oláh J; Ovádi J
Biochem Soc Trans; 2014 Dec; 42(6):1762-7. PubMed ID: 25399603
[TBL] [Abstract][Full Text] [Related]
5. Further evidence for microtubule-independent dimerization of TPPP/p25.
Oláh J; Szénási T; Szunyogh S; Szabó A; Lehotzky A; Ovádi J
Sci Rep; 2017 Jan; 7():40594. PubMed ID: 28074911
[TBL] [Abstract][Full Text] [Related]
6. TPPP/p25 promotes tubulin acetylation by inhibiting histone deacetylase 6.
Tokési N; Lehotzky A; Horváth I; Szabó B; Oláh J; Lau P; Ovádi J
J Biol Chem; 2010 Jun; 285(23):17896-906. PubMed ID: 20308065
[TBL] [Abstract][Full Text] [Related]
7. Identification of motives mediating alternative functions of the neomorphic moonlighting TPPP/p25.
Tőkési N; Oláh J; Hlavanda E; Szunyogh S; Szabó A; Babos F; Magyar A; Lehotzky A; Vass E; Ovádi J
Biochim Biophys Acta; 2014 Apr; 1842(4):547-57. PubMed ID: 24463170
[TBL] [Abstract][Full Text] [Related]
8. Role of the microtubule-associated TPPP/p25 in Parkinson's and related diseases and its therapeutic potential.
Oláh J; Bertrand P; Ovádi J
Expert Rev Proteomics; 2017 Apr; 14(4):301-309. PubMed ID: 28271739
[TBL] [Abstract][Full Text] [Related]
9. Localization of the zinc binding tubulin polymerization promoting protein in the mice and human eye.
Tripon RG; Oláh J; Nasir T; Csincsik L; Li CL; Szunyogh S; Gong H; Flinn JM; Ovádi J; Lengyel I
J Trace Elem Med Biol; 2018 Sep; 49():222-230. PubMed ID: 29317136
[TBL] [Abstract][Full Text] [Related]
10. Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.
Oláh J; Vincze O; Virók D; Simon D; Bozsó Z; Tõkési N; Horváth I; Hlavanda E; Kovács J; Magyar A; Szũcs M; Orosz F; Penke B; Ovádi J
J Biol Chem; 2011 Sep; 286(39):34088-100. PubMed ID: 21832049
[TBL] [Abstract][Full Text] [Related]
11. Microtubule assembly-derived by dimerization of TPPP/p25. Evaluation of thermodynamic parameters for multiple equilibrium system from ITC data.
Oláh J; Zotter Á; Hlavanda E; Szunyogh S; Orosz F; Szigeti K; Fidy J; Ovádi J
Biochim Biophys Acta; 2012 Jul; 1820(7):785-94. PubMed ID: 22484033
[TBL] [Abstract][Full Text] [Related]
12. Challenging drug target for Parkinson's disease: Pathological complex of the chameleon TPPP/p25 and alpha-synuclein proteins.
Szénási T; Oláh J; Szabó A; Szunyogh S; Láng A; Perczel A; Lehotzky A; Uversky VN; Ovádi J
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):310-323. PubMed ID: 27671864
[TBL] [Abstract][Full Text] [Related]
13. Zinc-induced structural changes of the disordered tppp/p25 inhibits its degradation by the proteasome.
Lehotzky A; Oláh J; Szunyogh S; Szabó A; Berki T; Ovádi J
Biochim Biophys Acta; 2015 Jan; 1852(1):83-91. PubMed ID: 25445539
[TBL] [Abstract][Full Text] [Related]
14. Interactions between two regulatory proteins of microtubule dynamics, HDAC6, TPPP/p25, and the hub protein, DYNLL/LC8.
Oláh J; Szunyogh S; Szénási T; Szaniszló T; Szabó A; Lehotzky A; Berki T; Nyitray L; Ovádi J
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118556. PubMed ID: 31505170
[TBL] [Abstract][Full Text] [Related]
15. Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors.
Mangas-Sanjuan V; Oláh J; Gonzalez-Alvarez I; Lehotzky A; Tőkési N; Bermejo M; Ovádi J
Br J Pharmacol; 2015 Feb; 172(3):829-40. PubMed ID: 25257800
[TBL] [Abstract][Full Text] [Related]
16. Anti-Aggregative Effect of the Antioxidant DJ-1 on the TPPP/p25-Derived Pathological Associations of Alpha-Synuclein.
Oláh J; Lehotzky A; Szénási T; Ovádi J
Cells; 2021 Oct; 10(11):. PubMed ID: 34831132
[TBL] [Abstract][Full Text] [Related]
17. Dynamic targeting of microtubules by TPPP/p25 affects cell survival.
Lehotzky A; Tirián L; Tökési N; Lénárt P; Szabó B; Kovács J; Ovádi J
J Cell Sci; 2004 Dec; 117(Pt 25):6249-59. PubMed ID: 15564385
[TBL] [Abstract][Full Text] [Related]
18. Modulatory Role of TPPP3 in Microtubule Organization and Its Impact on Alpha-Synuclein Pathology.
Oláh J; Lehotzky A; Szénási T; Berki T; Ovádi J
Cells; 2022 Sep; 11(19):. PubMed ID: 36230985
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological targeting of α-synuclein and TPPP/p25 in Parkinson's disease: challenges and opportunities in a Nutshell.
Oláh J; Ovádi J
FEBS Lett; 2019 Jul; 593(13):1641-1653. PubMed ID: 31148150
[TBL] [Abstract][Full Text] [Related]
20. Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies.
Kovács GG; László L; Kovács J; Jensen PH; Lindersson E; Botond G; Molnár T; Perczel A; Hudecz F; Mezo G; Erdei A; Tirián L; Lehotzky A; Gelpi E; Budka H; Ovádi J
Neurobiol Dis; 2004 Nov; 17(2):155-62. PubMed ID: 15474353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
